Cargando…

Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size

BACKGROUND: The clinical outcomes of endoscopic submucosal dissection (ESD) for undifferentiated (UD) intramucosal early gastric cancer (EGC) compared with those of surgery, regardless of lesion size, are not well known. Furthermore, there is a concern regarding the treatment plan before and after E...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Gil Ho, Lee, Eunyoung, Park, Bumhee, Roh, Jin, Lim, Sun Gyo, Shin, Sung Jae, Lee, Kee Myung, Noh, Choong-Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900575/
https://www.ncbi.nlm.nih.gov/pubmed/35317100
http://dx.doi.org/10.3748/wjg.v28.i8.840
_version_ 1784664152122327040
author Lee, Gil Ho
Lee, Eunyoung
Park, Bumhee
Roh, Jin
Lim, Sun Gyo
Shin, Sung Jae
Lee, Kee Myung
Noh, Choong-Kyun
author_facet Lee, Gil Ho
Lee, Eunyoung
Park, Bumhee
Roh, Jin
Lim, Sun Gyo
Shin, Sung Jae
Lee, Kee Myung
Noh, Choong-Kyun
author_sort Lee, Gil Ho
collection PubMed
description BACKGROUND: The clinical outcomes of endoscopic submucosal dissection (ESD) for undifferentiated (UD) intramucosal early gastric cancer (EGC) compared with those of surgery, regardless of lesion size, are not well known. Furthermore, there is a concern regarding the treatment plan before and after ESD in cases of UD intramucosal EGC within expanded indications. AIM: To evaluate clinical outcomes of ESD compared with those of surgery in UD intramucosal EGC patients regardless of tumor size. METHODS: We enrolled patients with UD intramucosal EGC after ESD with complete resection or surgery from January 2005 to August 2020 who met the within or beyond expanded indications with lesion size > 2 cm (the only non-curative factor). Overall, 123 and 562 patients underwent ESD and surgery, respectively. After propensity-score matching, clinical and long-term outcomes, i.e., recurrence-free survival (RFS) and overall survival (OS), were analyzed. The multivariable Cox proportional hazard model with treatment modality and ESD indication was used to evaluate the recurrence risk. RESULTS: After matching, 119 patients each were finally enrolled in the ESD and surgery groups. The median length of hospital stay was shorter in the ESD group than surgery group (4.0 vs 9.0 days, P < 0.001). Four cases of recurrence after ESD were local recurrences, all of which occurred within 1 year. Total recurrence was seven (5.9%) and two (1.7%) in the ESD and surgery groups, respectively. No difference was observed between the two groups with respect to OS (P = 0.948). However, the ESD group had inferior RFS compared with the surgery group (P = 0.031). ESD was associated with the risk of recurrence after initial treatment in all enrolled patients (hazard ratio, 5.2; 95% confidence interval: 1.0-25.8, P = 0.045). CONCLUSION: Although OS was similar between the two groups, surveillance endoscopy was important for the ESD than for the surgery group because RFS was inferior and local recurrence was an issue.
format Online
Article
Text
id pubmed-8900575
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-89005752022-03-21 Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size Lee, Gil Ho Lee, Eunyoung Park, Bumhee Roh, Jin Lim, Sun Gyo Shin, Sung Jae Lee, Kee Myung Noh, Choong-Kyun World J Gastroenterol Retrospective Study BACKGROUND: The clinical outcomes of endoscopic submucosal dissection (ESD) for undifferentiated (UD) intramucosal early gastric cancer (EGC) compared with those of surgery, regardless of lesion size, are not well known. Furthermore, there is a concern regarding the treatment plan before and after ESD in cases of UD intramucosal EGC within expanded indications. AIM: To evaluate clinical outcomes of ESD compared with those of surgery in UD intramucosal EGC patients regardless of tumor size. METHODS: We enrolled patients with UD intramucosal EGC after ESD with complete resection or surgery from January 2005 to August 2020 who met the within or beyond expanded indications with lesion size > 2 cm (the only non-curative factor). Overall, 123 and 562 patients underwent ESD and surgery, respectively. After propensity-score matching, clinical and long-term outcomes, i.e., recurrence-free survival (RFS) and overall survival (OS), were analyzed. The multivariable Cox proportional hazard model with treatment modality and ESD indication was used to evaluate the recurrence risk. RESULTS: After matching, 119 patients each were finally enrolled in the ESD and surgery groups. The median length of hospital stay was shorter in the ESD group than surgery group (4.0 vs 9.0 days, P < 0.001). Four cases of recurrence after ESD were local recurrences, all of which occurred within 1 year. Total recurrence was seven (5.9%) and two (1.7%) in the ESD and surgery groups, respectively. No difference was observed between the two groups with respect to OS (P = 0.948). However, the ESD group had inferior RFS compared with the surgery group (P = 0.031). ESD was associated with the risk of recurrence after initial treatment in all enrolled patients (hazard ratio, 5.2; 95% confidence interval: 1.0-25.8, P = 0.045). CONCLUSION: Although OS was similar between the two groups, surveillance endoscopy was important for the ESD than for the surgery group because RFS was inferior and local recurrence was an issue. Baishideng Publishing Group Inc 2022-02-28 2022-02-28 /pmc/articles/PMC8900575/ /pubmed/35317100 http://dx.doi.org/10.3748/wjg.v28.i8.840 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Retrospective Study
Lee, Gil Ho
Lee, Eunyoung
Park, Bumhee
Roh, Jin
Lim, Sun Gyo
Shin, Sung Jae
Lee, Kee Myung
Noh, Choong-Kyun
Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size
title Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size
title_full Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size
title_fullStr Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size
title_full_unstemmed Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size
title_short Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size
title_sort long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900575/
https://www.ncbi.nlm.nih.gov/pubmed/35317100
http://dx.doi.org/10.3748/wjg.v28.i8.840
work_keys_str_mv AT leegilho longtermoutcomesofendoscopicsubmucosaldissectionandsurgeryforundifferentiatedintramucosalgastriccancerregardlessofsize
AT leeeunyoung longtermoutcomesofendoscopicsubmucosaldissectionandsurgeryforundifferentiatedintramucosalgastriccancerregardlessofsize
AT parkbumhee longtermoutcomesofendoscopicsubmucosaldissectionandsurgeryforundifferentiatedintramucosalgastriccancerregardlessofsize
AT rohjin longtermoutcomesofendoscopicsubmucosaldissectionandsurgeryforundifferentiatedintramucosalgastriccancerregardlessofsize
AT limsungyo longtermoutcomesofendoscopicsubmucosaldissectionandsurgeryforundifferentiatedintramucosalgastriccancerregardlessofsize
AT shinsungjae longtermoutcomesofendoscopicsubmucosaldissectionandsurgeryforundifferentiatedintramucosalgastriccancerregardlessofsize
AT leekeemyung longtermoutcomesofendoscopicsubmucosaldissectionandsurgeryforundifferentiatedintramucosalgastriccancerregardlessofsize
AT nohchoongkyun longtermoutcomesofendoscopicsubmucosaldissectionandsurgeryforundifferentiatedintramucosalgastriccancerregardlessofsize